Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Kidney International Reports|November 22, 2021
Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKDNathalie Demoulin, Victoria Nicola, Nicolas Michoux, et al.
Kidney International Reports|May 21, 2026
Living Donor Kidney Transplantation in High-Recurrence Kidney Diseases: Precision Risk Stratification and ManagementCatherine Verhellen, Arnaud Devresse, Valentine Gillion, et al.
Pediatric Nephrology (Berlin, Germany)|January 16, 2023
Severe parental phenotype associates with hypertension in children with ADPKDNathalie Demoulin, Elliott Van Regemorter, Karin Dahan, et al.
Kidney International Reports|March 14, 2024
Monogenic Kidney Diseases in Kidney TransplantationValentine Gillion, Arnaud Devresse, Eric Olinger, et al.
Transplantation|August 29, 2024
Bridging the Gap Between CKD Management Paradigms in Transplant and Nontransplant Settings: Published Evidence, Challenges, and PerspectivesInès Dufour, Elliott Van Regemorter, Nada Kanaan, et al.
Kidney International Reports|June 2, 2018
Genotype and Outcome After Kidney Transplantation in Alport SyndromeValentine Gillion, Karin Dahan, Jean-Pierre Cosyns, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2026
Albuminuria drives hyperlipidemia in patients with Alport syndromeOliver Gross, Annika Jens, Agne Cerkauskaite-Kerpauskiene, et al.
Kidney International Reports|July 26, 2021
Recurrence and Outcome of Anti-Glomerular Basement Membrane Glomerulonephritis After Kidney TransplantationSophie Coche, Ben Sprangers, Steven Van Laecke, et al.
Kidney International|September 12, 2020
Cystinuria: clinical practice recommendationAude Servais, Kay Thomas, Luca Dello Strologo, et al.
Kidney International Reports|December 19, 2024
SGLT2-Inhibition in Patients With Alport SyndromeJan Boeckhaus, Daniel P Gale, James Simon, et al.
Pageof 3